In multiple disorders, high levels of circulating HMGB1 act as a general biomarker that correlates with disease severity in diseases such as Parkinson's, autism, multiple sclerosis, and amyotrophic lateral sclerosis (Venereau et al., 2016; Mao et al., 2022). Here, HMGB1 is linked to amyotrophic lateral sclerosis.